Literature DB >> 19741522

Role of interleukins in the regulation of basophil development and secretion.

Peter Valent1, Clemens A Dahinden.   

Abstract

PURPOSE OF REVIEW: It is well appreciated that differentiation, growth, and function of basophils are regulated by a network of cytokines, and that these cells express a unique composition of surface receptors including interleukin-binding sites. In the current article, most recent discoveries around cytokine regulation of basophils are discussed and compared with previous data. RECENT
FINDINGS: Confirming previous studies, the most potent growth factor for basophils remains interleukin (IL)-3, followed by granulocyte-macrophage colony-stimulating factor and IL-5. These cytokines also act on mature basophils through specific receptors, thereby mediating adhesion, migration, and releasability. Other molecules regulating basophil function are chemokines such as IL-8 or eotaxin and IL-33. Especially IL-33 has been described as a novel basophil regulator. All cytokines act on basophils via specific receptors and signal transduction pathways. The present article provides a summary of our knowledge on cytokine regulation of basophils and receptor expression, with emphasis on most recent developments in the field.
SUMMARY: Basophil regulation by cytokines in health and disease may be a more complex process than has been considered previously. Some of the affected cytokine cascades, receptors, and signal transduction molecules may serve as targets of therapy in 'basophil activation disorders' in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19741522     DOI: 10.1097/MOH.0b013e328331fae9

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  7 in total

1.  Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.

Authors:  Ying Song; Chunfeng Qu; Kamal Srivastava; Nan Yang; Paula Busse; Wei Zhao; Xiu-Min Li
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

2.  Basophils are not the key antigen-presenting cells in allergic patients.

Authors:  J Eckl-Dorna; A Ellinger; K Blatt; V Ghanim; I Steiner; M Pavelka; P Valent; R Valenta; V Niederberger
Journal:  Allergy       Date:  2012-02-16       Impact factor: 13.146

3.  Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression.

Authors:  Corrado Pelaia; Claudia Crimi; Alida Benfante; Maria Filomena Caiaffa; Cecilia Calabrese; Giovanna Elisiana Carpagnano; Domenico Ciotta; Maria D'Amato; Luigi Macchia; Santi Nolasco; Girolamo Pelaia; Simona Pellegrino; Nicola Scichilone; Giulia Scioscia; Giuseppe Spadaro; Giuseppe Valenti; Alessandro Vatrella; Nunzio Crimi
Journal:  J Asthma Allergy       Date:  2021-02-22

Review 4.  Treatment of allergic asthma: modulation of Th2 cells and their responses.

Authors:  Berislav Bosnjak; Barbara Stelzmueller; Klaus J Erb; Michelle M Epstein
Journal:  Respir Res       Date:  2011-08-25

5.  Increased expression levels of CD300c on basophils from allergic individuals.

Authors:  Joana Vitallé; Iñigo Terrén; Ane Orrantia; Aritza Segurola; Yolanda Seras; Pedro M Gamboa; Francisco Borrego; Olatz Zenarruzabeitia
Journal:  World Allergy Organ J       Date:  2019-09-30       Impact factor: 4.084

Review 6.  Behind the scenes with basophils: an emerging therapeutic target.

Authors:  Hemali Shah; Stephanie Eisenbarth; Christopher A Tormey; Alexa J Siddon
Journal:  Immunother Adv       Date:  2021-05-19

7.  Adhesion molecule cross-linking and cytokine exposure modulate IgE- and non-IgE-dependent basophil activation.

Authors:  Frida Kalm; Ladan Mansouri; Aman Russom; Joachim Lundahl; Anna Nopp
Journal:  Immunology       Date:  2020-10-29       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.